Over the last decade, immunotherapy became a standard of care for the clinical management of cancer patients across various malignancies. There is now a strong rationale for oncologists and young scientists to become acquainted to deep and comprehensive immunology, at the cross roads with oncogenesis and microbiology.
Mechanisms of action as to how the immune system impacts clinical responses and interacts with intestinal biology will be detailed. Preclinical in vitro and in vivo methods including high dimensional immunology will be explained.
Host
- Faculty of Medicine Paris-Saclay
Registration
- Open (Deadline: 15 Nov 2021)
Dieser Online-Kurs findet auf English statt. Weitere Informationen finden Sie auf der EUGLOH-Website.
Die European University Alliance for Global Health (EUGLOH) ist eine strategische Partnerschaft zwischen der Université Paris-Saclay, der Universität Lund, der Ludwig-Maximilians-Universität München, der Universidade do Porto und der Universität Szeged im Rahmen der Europäischen Hochschulinitiative der Europäischen Kommission.